Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
Acta Neuropsychiatrica|February 14, 2025
Association of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and neurogenesis: a systematic reviewHezekiah C T Au, Yang Jing Zheng, Gia Han Le, et al.
Psychoneuroendocrinology|April 3, 2026
The effect of GLP-1 receptor agonists on anxiety: A systematic reviewYu Tian Yi, Yang Jing Zheng, Stavroula I Bargiota, et al.
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled TrialAngela T H Kwan, Moiz Lakhani, Gia Han Le, et al.
Current Medical Research and Opinion|July 2, 2024
Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a post-hoc analysisSonya Liao, Kayla M Teopiz, Angela T H Kwan, et al.
CNS Spectrums|May 26, 2025
Should glutamatergic modulators be considered preferential treatments for adults with major depressive disorder and a reported history of trauma? Conceptual and clinical implicationsKayla M Teopiz, Heidi K Y Lo, Moiz Lakhani, et al.
Journal of Affective Disorders|February 1, 2026
The effect of glucagon-like peptide 1 (GLP-1) receptor agonists on cognition: A systematic review of systematic reviews and meta-analysesHana Ballum, Christine Dri, Sonya Liao, et al.
European Archives of Psychiatry and Clinical Neuroscience|August 27, 2024
Subjective and objective measures of cognitive function are correlated in persons with Post-COVID-19 Condition: a secondary analysis of a Randomized Controlled TrialAngela T H Kwan, Moiz Lakhani, Gia Han Le, et al.
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Subjective and Objective Measures of Cognitive Function are Correlated in Persons with Post-COVID-19 Condition: A Secondary Analysis of a Randomized Controlled TrialAngela T H Kwan, Moiz Lakhani, Gia Han Le, et al.
CNS Spectrums|December 10, 2024
Impact of depressive symptoms on motivation in persons with post-COVID-19 conditionJuliana West, Angela T H Kwan, Kayla M Teopiz, et al.
Journal of Affective Disorders|April 3, 2024
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic reviewGia Han Le, Sabrina Wong, Sebastian Badulescu, et al.
Pageof 10